Carfilzomib in Refractory Renal Cell Carcinoma (RCC)

Carfilzomib in Refractory Renal Cell Carcinoma (RCC)

Sponsors and Collaborators
M.D. Anderson Cancer Center
Onyx Therapeutics, Inc.

Contact
Eric Jonasch, MD
713-792-2830

Principal Investigator
Eric Jonasch, MD, UT MD Anderson Cancer Center

ClinicalTrials.gov Identifier
NCT01775930

Loading links....
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters